Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with a history of hormone receptor-negative breast cancer.

Trial Profile

Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with a history of hormone receptor-negative breast cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Sep 2014

At a glance

  • Drugs Polyphenon E (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions; Biomarker
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 21 Jun 2012 Planned end date changed from 1 Jun 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
    • 15 Nov 2011 Planned end date changed from 1 Jun 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top